TABLE I.
Preclinical Study to Determine the Effects of Dasatinib on Fertility and Early Embryonic Development
Male rats | Female rats | |||||
---|---|---|---|---|---|---|
Dasatinib (mg/kg/day) | ||||||
Drug-related changesa | 2.5 | 5 | 10 | 2.5 | 5 | 10 |
Mating rate | NC | NC | NC | NC | NC | NC |
Fertility rate | NC | NC | NC | NC | NC | NC |
Embryolethality | NC | NC | NC | NC | I | I |
Postimplantation loss of embryos | NC | NC | NC | NC | I | I |
Seminal vesicle weights with fluid | NC | NC | D | N/A | N/A | N/A |
Viability | NC | NC | NC | NC | NC | NC |
Mild/moderate dehydration | NC | I | I | NC | NC | I |
Body weight (males) | NC | D | D | N/A | N/A | N/A |
Body weight gain (females) | N/A | N/A | N/A | NC | D | D |
Food intake | NC | D | D | NC | NC | D |
Compared with untreated controls.
I. increased; D, decreased; NC, no change; N/A, not applicable.